Table 2 Example of results from a crossover study reporting PD₁₅ on the original and dose doubling (DD) scale [26]

1

188.6

379

2.01

7.559

8.566

1.007

2

36.2

 ≥ 635

17.54

5.178

9.311

4.133

3

76.8

569

7.41

6.263

9.152

2.889

4

 > 635

 > 635

1.00

9.311

9.311

0.000

5

292.4

 > 635

2.17

8.192

9.311

1.119

6

210

 > 635

3.02

7.714

9.311

1.596

7

234.7

 > 635

2.71

7.875

9.311

1.436

8

86.6

328.6

3.79

6.436

8.360

1.924

9

561.3

 > 635

1.13

9.133

9.311

0.178

10

258.8

 > 635

2.45

8.016

9.311

1.295

11

128.4

285.5

2.22

7.005

8.157

1.153

12

76.8

122.8

1.60

6.263

6.940

0.677

13

104.1

122.5

1.18

6.702

6.937

0.235

14

 > 635

 > 635

1.00

9.311

9.311

0.000

15

106.7

 > 635

5.95

6.737

9.311

2.573

16

104.4

170.3

1.63

6.706

7.412

0.706

17

38.7

499.9

12.92

5.274

8.965

3.691

18

223.2

 > 635

2.84

7.802

9.311

1.508

19

124.2

368.9

2.97

6.957

8.527

1.571

20

100.2

172.8

1.72

6.647

7.433

0.786

21

24.8

122.8

4.95

4.632

6.940

2.308

22

142.2

554.5

3.90

7.152

9.115

1.963

23

630.4

 > 635

1.01

9.300

9.311

0.010

24

401.9

 > 635

1.58

8.651

9.311

0.660

Geometric Mean

155.8

409.1

2.63

7.284

8.676

1.392

(95% CI)

(107.0–227.1)

(317.7–526.9)

(2.56–2.69)

(6.741–7.827)

(8.311–9.041)

(1.357–1.428)